New steps forward for obstructive sleep apnoea in the era of precision medicine

Obstructive sleep apnoea (OSA) is a progressive disorder characterised by repeated upper-airway collapse during sleep that leads to intermittent hypoxia and hypercapnia, fragmented sleep, fluctuations in blood pressure and increased sympathetic nervous system activity [1]. Population studies in the early 1990s found OSA (defined by an apnoea–hypopnoea index (AHI) >5 events·h–1) in 9% of middle-aged women and 24% of middle-aged men [2].

Source: European Respiratory Journal - September 16, 2018 Category: Respiratory Medicine Authors: Peker, Y., Strollo, P. J. Tags: Sleep medicine Editorials Source Type: research